**Core tip:** This study evaluates the effectiveness of a novel, polyurethane based, surgical adhesive on a liver resection model. This study will further help in better sealing of wounds in a trauma model in comparison to Fibrin glue.

INTRODUCTION
============

Hemorrhage due to traumatic injury is one of the leading causes of death worldwide. It is estimated that hemorrhage is responsible for more than 35% of pre-hospital mortality and 40% of mortality in the first 24 h\[[@B1]\]. In case of abdominal trauma, the liver is one of the most commonly injured organs; anatomical position and its delicate parenchyma make it susceptible to injury and hemorrhage\[[@B2]\]. Despite modern surgical techniques, management of hemorrhage after liver trauma still remains a challenge, with major liver trauma resulting in high morbidity and mortality rates\[[@B3]\]. Furthermore, surgeries involving liver resection are known to be of high risk; nevertheless, it is the one of the curative treatment options for hepatocellular cancer patients\[[@B4]\].

Management of liver injury has progressed tremendously in the last three decades\[[@B2]\]. Advancement in biotechnological research has resulted in a variety of hemostatic agents\[[@B5]\]. These hemostatic agents are either biological or synthetic in nature\[[@B5]\]. They are based on components including cellulose, collagen, glutaraldehyde, fibrin, and dihydroxyacetone\[[@B5]-[@B7]\]. Fibrin sealants (also known as fibrin adhesive or glue) are the most widely used hemostatic agents as a complimentary adjunct in various surgical procedures. Fibrin sealants comprise of two components, human-thrombin and fibrinogen, usually plasma derived\[[@B5]\]. During application, these two components interact to form a stable fibrin clot\[[@B5]\]. However, most require 2 °C-8 °C storage, extensive preparation, and, once taken out of refrigeration, have to be used within 9 h\[[@B6]\]. Notably, fibrin sealants are less effective in events of strong bleeding, as they can be washed away with blood or other liquids and there is a risk of re-bleeding, due to fibrin sealants' limited sealing strength\[[@B8],[@B9]\]. Due to their biological origin, fibrin sealants are associated with risk factors including immune reactions, viral transmission, and potential embolism risk\[[@B6],[@B10],[@B11]\].

In the early forties, cyanoacrylate based glues were marketed under brand names, such as, Superglue and Krazy glue. Cyanoacrylate glues are neither biocompatible nor bioabsorbable\[[@B12]\]. Additionally, upon degradation, cyanoacrylates form cyanoacetate and formaldehyde, which are toxic to humans\[[@B5],[@B12]\]. Other options for synthetic products include urethane based polymers, such as polyurethane. Polyurethanes (PUs) are known for their tensile strength of 4-60 MPa; thus, making them highly elastic\[[@B13]\]. Research has shown that several factors, such as hydrolysis and enzymatic action, contribute to their degradation\[[@B14]\]. Because of their non-biological components, there is no risk of virus transmission or antigenic reaction like with fibrin based adhesives.

The aim of this study was to evaluate MAR-1, determining hemostatic properties, functionality, and prevention of intra-abdominal adhesions, tissue compatibility as well as biodegradation. In comparison, we tested the clinically used fibrin sealant Beriplast^®^ P (CSL Behring GmbH, Marburg, Germany) and Sodium Chloride (NaCl) as a control solution.

MATERIALS AND METHODS
=====================

MAR-1 and Fibrin sealant
------------------------

MAR-1 is a polyurethane based sealant that consists of two different components: A isocyanate-functional polyester-ether pre-polymer and an amino-functional asparagine acid ester. This adhesive technology and its polyaddition reaction are well-known.

The two components were stored at 22 °C in a double chamber syringe and combined upon application (Adhesys Medical GmbH, Aachen, Germany). The Fibrin sealant used was the commercially available Beriplast^®^ P (CSL Behring GmbH, Marburg, Germany), which consists of fibrin and thrombin mixed prior to application.

Animals and surgical procedure
------------------------------

All experiments were conducted in accordance with German Federal Law regarding the protection of animals and the DIRECTIVE 2010/63/EU on the protection of animals used for scientific purposes. The Guide for the care and use of laboratory animals (8^th^ edition, NIH Publication, 2011, United States) was also followed. The governmental care and use committee (LANUV), Recklinghausen, NRW, Germany, granted official permission. Male Wistar rats weighing between 200-260 g were used. The animals were housed in Type 2000 rat filter top cages (Tecniplast, Hohenpreisenberg, Germany) under specific pathogen free (SPF)-conditions according to Federation of European Laboratory Animal Science Associations (FELASA) guidelines ([www.felasa.eu](www.felasa.eu)), in a temperature (22 °C) and humidity controlled environment (55% relative humidity) with a 12-h light/dark cycle and allowed food (standard rat diet, Ssniff-Spezial Diäten GmbH, Soest, Germany) and water ad libitum.

Sixty-three rats were randomly allocated to the following groups: MAR-1, Fibrin and NaCl. The groups were further classified into three time points: 14 d, 21 d, and 90 d. Rats received general anesthesia by inhalation of 1.5% isoflurane (Abbott GmbH and Co.KG, Wiesbaden, Germany) and administration of 0.1 mg/kg body weight Buprenorphine (Temgesic^®^, Essex Pharma GmbH, Munich, Germany) subcutaneously as analgesic. For perioperative anti-biotic prophylaxis, rats received 16 mg/kg bodyweight Cefuroxime s.c. (Fresenius SE and Co. KGaA, Homburg, Germany). Using a vessel loop for compression, 30% of the left lateral lobe was removed, and sealant was applied in an amount sufficient to cover the wound area. Pre-weighed gauze was placed under the liver lobe prior to resection. Post resection, the blood absorbed by the gauze was weighed and subtracted from the pre-weight of the gauze to calculate the bleeding mass. The animals were euthanized under anesthesia after 14, 21 and 90 d respectively.

μ***CT to visualize the biodegradation***

μCT data was measured using Tomoscope 30 s Duo (CT-Imaging GmbH, Erlangen, Germany) using a protocol (HQD-6565-90-360) that took 720 projections (1032 × 1012 Pixel) in 90 s during one rotation with radiation dose of 421 mGy\[[@B15]\]. Several sub-scans were taken and reconstructed using a Feldkamp algorithm with a voxelsize of 70 μm × 70 μm × 70 μm and were assembled into one volume data set. Volumetric image data was analyzed and visualized using the Imalytics Preclinical Software\[[@B16]\].

Histological evaluation
-----------------------

Tissue samples of the liver were collected at the time when the rats were euthanized. The samples were immediately fixed in 4% neutral buffered formalin (Roti^®^-Histofix 4%, Roth, Karlsruhe-Germany), and then were shaken overnight on a shaker (Lab net, International Inc., United States). The specimens were processed in grading series of alcohol and xylene, embedded in paraffin and sectioned at 4-6 μm thin slices using a microtome and were stained with hematoxylin and eosin (H and E). Paraffin-embedded liver sections were used for H and E staining and analysed using a Leica DM 2500 microscope (Leica, Bensheim, Germany).

Immunohistochemistry was performed as per manufacturer's instructions. CD68 macrophages were identified by a 1:50 mouse monoclonal antibody from Dako (Glostrup, Denmark), pre-treatment of the fixed specimen with microwave three times, citrate-buffer pH 6, and as secondary antibody rabbit anti-mouse 1:300 from Dako (Glostrup, Denmark).

Serum analyses and hematology
-----------------------------

Serum was withdrawn at 14, 21 and 90 d post operation and analyzed with a clinical chemistry analyzer (Ortho Clinical Diagnostics GmbH, Neckargemünd, Germany). Liver enzymes, ALT and AST were measured from serum. In addition, blood count of leukocytes (10^3^/μL), erythrocytes (10^6^/μL), platelets (10^3^/μL), and hemoglobin were measured using the MEK6450K automatic cell counter (Nihon Kohden, Rosbach, Germany).

Statistical analysis
--------------------

Statistical review was performed by Professor René Tolba. All results are expressed as mean ± SEM and the data was analyzed by Graph Pad Prism^®^ Version 5 (Graph Pad, San Diego, CA, United States). Significance between different groups was measured with one-way analysis of variance (ANOVA) and posttest: Tukey-Kramer. Survival analysis was carried out by Kaplan-Meier curve and Mantel-Cox test. Values of *P* \< 0.05 were considered statistically significant.

RESULTS
=======

Bleeding mass
-------------

Bleeding mass (Figure [1](#F1){ref-type="fig"}) was assessed in order to record the amount of blood lost after liver resection. After 21 d, NaCl (3.36 ± 0.51 g) showed significantly higher levels of blood loss in comparison to MAR-1 (1.44 ± 0.40 g) and Fibrin (1.16 ± 0.32 g) treated animals. However, there were no significant differences between the animals in 14 d (MAR-1: 2.08 ± 0.30 g; Fibrin: 1.02 ± 0.29 g; NaCl: 1.02 ± 0.29 g) and 90 d (MAR-1: 2.21 ± 0.44 g; Fibrin: 2.03 ± 0.28 g; NaCl: 3.04 ± 0.50 g) group.

![Amount of blood loss was measured at three different time points. ^b^*P* \< 0.001 MAR-1 *vs* NaCl; ^d^*P* \< 0.01 Fibrin *vs* NaCl in 21 d group (*n* = 7).](WJH-9-1030-g001){#F1}

Bleeding time
-------------

Duration of blood loss (Figure [2](#F2){ref-type="fig"}) was recorded to evaluate the bleeding time in different groups. NaCl (158.16 ± 11.36 s) (127.5 ± 23.3 s) showed significantly higher bleeding times on 14 and 90 d in comparison to MAR-1 (6.0 ± 0.9 s) (13.57 ± 3.22 s) and Fibrin (3.0 ± 0.44 s) (22.2 ± 9.75 s) groups respectively. However, the groups showed no significance at 21 d time point (MAR-1: 25.33 ± 17.53 s; Fibrin: 61.16 ± 56.77 s; NaCl: 10.71 ± 1.19 s).

![Bleeding time was recorded after liver resection. ^b^*P* \< 0.001 MAR-1 and Fibrin *vs* NaCl in both 14 and 90 d group (*n* = 7).](WJH-9-1030-g002){#F2}

Aspartate transaminase
----------------------

Aspartate transaminase (Figure [3](#F3){ref-type="fig"}) was measured as parameter for liver injury. There were no significant differences noticed in the groups at 14 (MAR-1: 30.37 ± 1.23 U/L; Fibrin: 27.83 ± 2.54 U/L; NaCl: 29.16 ± 2.12 U/L), 21 (MAR-1: 31.77 ± 1.80 U/L; Fibrin: 25.33 ± 1.70 U/L; NaCl: 31.00 ± 2.46 U/L) or 90 d (MAR-1: 31.28 ± 2.86 U/L; Fibrin: 27.90 ± 1.86 U/L; NaCl: 25.83 ± 2.71 U/L).

![Aspartate transaminase release was measured after 21 and 90 post-operative days (*n* = 7). AST: Aspartate transaminase.](WJH-9-1030-g003){#F3}

Alanine transaminase
--------------------

Alanine transaminase (Figure [4](#F4){ref-type="fig"}) release was measured as a parameter for liver parenchymal damage. Significant differences between the treatment groups were seen after 14 and 21 post-operative days. Fibrin (28.5 ± 0.42 U/L: 14 d) (24.16 ± 0.98 U/L: 21 d) showed a significantly higher release of ALT compared to NaCl (24.5 ± 1.23 U/L: 14 d) (23.85 ± 0.80 U/L: 21 d) group after 14 d. Meanwhile, MAR-1 (26.37 ± 0.92 U/L: 14 d) (27.66 ± 1 U/L: 21 d) showed significantly higher levels after 21 d in comparison to both NaCl and Fibrin treated animals.

![Alanine transaminase release was measure after 14, 21 and 90 post-operative days. ^a^*P* \< 0.05 Fibrin *vs* NaCl after 14 d; ^a^*P* \< 0.05 MAR-1 *vs* Fibrin; ^b^*P* \< 0.01 MAR-1 *vs* NaCl after 21 post-operative days (*n* = 7). ALT: Alanine transaminase.](WJH-9-1030-g004){#F4}

Adhesions
---------

Intra-abdominal adhesions (Figure [5](#F5){ref-type="fig"}) were visualized and the extent of adhesions was evaluated. After 14 d, Fibrin (13.33% ± 6.1%) treated animals showed significantly lower percentage of adhesions in comparison to NaCl (68.33% ± 14.24%). MAR-1 (11.22% ± 5.5%) showed significantly lower adhesion compared to NaCl (58.57% ± 11.83%) after 21 d. After 90 d, Fibrin group (24% ± 7.29%) showed significantly lower levels of adhesions compared to NaCl group (61.66% ± 7.03%). Whereas, there were no significant differences found between Fibrin and MAR-1 groups at any given time point.

![Percentage of tissue adhesion after 14, 21 and 90 post-operative days was tabulated. ^b^*P* \< 0.01 Fibrin *vs* NaCl after 14 d, ^b^*P* \< 0.01 MAR-1 *vs* NaCl after 21 d; ^a^*P* \< 0.05 Fibrin *vs* NaCl after 90 d (*n* = 7).](WJH-9-1030-g005){#F5}

Degradation
-----------

μCT scans were performed on day 1 and day 7 to visualize the glue. Interestingly, due to its hydrogel like properties, the glue could not be distinguished from the liver tissue in the µCT images (Figure [6](#F6){ref-type="fig"}). Degradation of MAR-1 and Fibrin were noted and compared to NaCl treatment. MAR-1 (0% ± 0% at all time points) and NaCl (0%) were absent or negligible compared to Fibrin (10% ± 5% 14 d; 7% ± 3% 21 d; 0% 90 d). Fibrin glue levels were significantly higher compared to MAR-1 and NaCl groups after 14 and 21 d. Fibrin glue was completely metabolized after 90 d.

![µCT scans of MAR-1 rat on day 1 and day 7. Percentage of adhesive degradation was evaluated after 14, 21 and 90 post-operative days. ^d^*P* \< 0.001 Fibrin *vs* MAR-1 and NaCl after 14 d; ^b^*P* \< 0.01 Fibrin *vs* MAR-1; ^a^*P* \< 0.05 NaCl *vs* Fibrin 21 d (*n* = 7). L: Liver, S: Stomach, V: Vertebra.](WJH-9-1030-g006){#F6}

Survival rate
-------------

Percentage survival (Figure [7](#F7){ref-type="fig"}) was calculated for each treatment group. MAR-1 showed a survival percentage of 95.83% in comparison to Fibrin with 95.65% and NaCl with 95%. As per Mantel-Cox test, the *P* value was 0.9906 and there was no statistical significance seen between MAR-1 and other the groups.

![Survival proportions between the treatment groups were calculated during 14, 21 and 90 post-operative days. *P* = 0.9906 as per Mantel-Cox test (*n* = 7).](WJH-9-1030-g007){#F7}

Histopathology
--------------

Histopathological evaluation (Figure [8](#F8){ref-type="fig"}) was performed on the tissue section after 90 post-operative days. There was a slight inflammation due to foreign body reaction in both MAR-1 and Fibrin groups. The reaction zone showed granulation tissue along with some collagen structures. A dense collagenous fibrotic tissue along with histiocytic inflammation was noticed. Whereas, in MAR-1 and Fibrin treated animals inflammation was noticed initially; however, the reaction was absent after 90 d. In case of NaCl treated animals, a thicker liver capsule was seen and occasional inflammation due to bleeding remnants.

![Histopathological evaluations of H and E stained liver tissue section shows the resected area and structural intergrity at different time points, MAR-1 (A: 14 d, B: 21 d, C: 90 d); Fibrin (D: 14 d, E: 21 d, F: 90 d); NaCl (G: 14 d, H: 21 d, I: 90 d).](WJH-9-1030-g008){#F8}

CD68
----

Immunohistochemical staining is an ideal tool to identify the presence of CD68 positive cells (Figure [9](#F9){ref-type="fig"}). It specifically stains macrophages as well as Kupffer cells, Giant cells, and Monocytes. This helps in recognizing cell proliferation in tissues. The CD68 cell count at 14 d (8.6 ± 1.0, 9.0 ± 1.0 AU, 6.8 ± 0.8 AU), 21 d (5.4 ± 0.6 AU, 5.6 ± 0.67 AU, 2.4 ± 1.0 AU), and 90 d (1.6 ± 0.5 AU, 2.4 ± 0.6 AU, 2.4 ± 1.0 AU) showed no significant differences within the groups.

![Immunohistochemical staining for CD68 shows a few darkly stained positive cells. The graph represents the CD68 positive cell count with no significant differences between the groups, MAR-1 (A: 14 d; B: 21 d; C: 90 d); Fibrin (D: 14 d, E: 21 d, F: 90 d); NaCl (G: 14 d, H: 21 d, I: 90 d).](WJH-9-1030-g009){#F9}

Elastic van Gieson
------------------

Elastic van Gieson staining (Figure [10](#F10){ref-type="fig"}) protocol specifically stains elastic fibers, which helps in differentiating between normal and pathological elastic fibers. Due to the chemical reaction in the staining process, the elastic fibers and cell nuclei are stained black, collagen fibers are stained red, and other tissue elements including cytoplasm are stained yellow. We noticed the width of the reaction zone along with the proliferative tissue reduced with time and there were no significant changes noticed in the structural integrity.

![Elastic van Gieson staining shows the resected area and proliferative tissue, MAR-1 (A: 14 d, B: 21 d, C: 90 d); Fibrin (D: 14 d, E: 21 d, F: 90 d); NaCl (G: 14 d, H: 21 d, I: 90 d).](WJH-9-1030-g010){#F10}

Hematological parameters
------------------------

Leucocytes, Erythrocytes, Hematocrit, and Platelets were measured and the groups showed no significant differences (Table [1](#T1){ref-type="table"}). However, Hemoglobin levels (Table [1](#T1){ref-type="table"}) were measured in all the groups. There was a significant difference noted between Fibrin (11.69 ± 0.21 g/dL) and NaCl groups (12.48 ± 0.17 g/dL) at baseline level. Whereas, MAR-1 (12.09 ± 0.29 g/dL) showed significantly lower haemoglobin levels compared to NaCl group (13.68 ± 0.26 g/dL).

###### 

Leucocytes in 103/μL; Erythrocytes in 106/μL; Hemoglobin in g/dL; Hematocrit in %; Platelets in 103/μL; (mean ± SEM); 1-way ANOVA, Posttest: Tukey Kramer

                                                                **MAR-1**      **Fibrin**                                     **NaCl**                                       ***P* value**
  -------------- ---------------------------------------------- -------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------
  Leucocytes     0 d                                            7.48 ± 0.33    6.82 ± 0.30                                    7.26 ± 0.39                                    NS
  14 d           6.78 ± 0.66                                    7.18 ± 0.67    8.65 ± 0.75                                    NS                                             
  21 d           7.56 ± 0.75                                    7.20 ± 0.72    6.23 ± 0.50                                    NS                                             
  90 d           6.11 ± 0.78                                    5.76 ± 0.52    5.41 ± 0.32                                    NS                                             
  Erythrocytes   0 d                                            5.71 ± 0.09    5.68 ± 0.07                                    5.68 ± 0.08                                    NS
  14 d           6.07 ± 0.17                                    6.48 ± 0.20    6.03 ± 0.18                                    NS                                             
  21 d           6.33 ± 0.14                                    7.03 ± 0.10    6.50 ± 0.17                                    NS                                             
  90 d           7.58 ± 0.19                                    7.51 ± 0.12    7.72 ± 0.17                                    NS                                             
  Hemoglobin     0 d                                            12.29 ± 0.14   11.69 ± 0.21[a](#T1FN1){ref-type="table-fn"}   12.48 ± 0.17[a](#T1FN1){ref-type="table-fn"}   [a](#T1FN1){ref-type="table-fn"}*P* \< 0.05
  14 d           12.09 ± 0.29[b](#T1FN2){ref-type="table-fn"}   13.13 ± 0.43   13.68 ± 0.26[b](#T1FN2){ref-type="table-fn"}   [b](#T1FN2){ref-type="table-fn"}*P* \< 0.01    
  21 d           13.08 ± 0.22                                   13.84 ± 0.28   14.17 ± 0.28                                   NS                                             
  90 d           14.14 ± 0.33                                   13.88 ± 0.18   13.90 ± 0.29                                   NS                                             
  Hematocrit     0 d                                            35.09 ± 0.48   34.59 ± 0.30                                   34.05 ± 0.42                                   NS
  14 d           35.66 ± 0.96                                   38.30 ± 0.94   35.13 ± 0.50                                   NS                                             
  21 d           35.50 ± 0.76                                   36.98 ± 0.62   36.31 ± 1.02                                   NS                                             
  90 d           39.69 ± 0.91                                   39.26 ± 0.55   39.75 ± 0.94                                   NS                                             
  Platelets      0 d                                            923 ± 32       960 ± 42                                       998 ± 30                                       NS
  14 d           907 ± 67                                       985 ± 63       1035 ± 34                                      NS                                             
  21 d           1104 ± 50                                      1024 ± 57      970 ± 41                                       NS                                             
  90 d           924 ± 42                                       874 ± 25       916 ± 48                                       NS                                             

*P* \< 0.05;

*P* \< 0.01.

DISCUSSION
==========

According to WHO 2010 database, 5.8 million deaths due to injuries were recorded worldwide\[[@B17]\]. A quarter of these were due to trauma and hemorrhagic shock due to injuries; thus, making it a leading cause of death across the globe\[[@B1],[@B17]\]. Liver injury is most commonly observed in abdominal trauma cases\[[@B18]\]. Apart from trauma, liver resection in hepatocellular carcinoma patients carries a high risk of hemorrhage\[[@B19]\]. Hemorrhage during liver surgery is directly associated with extensive use of vascular occlusion techniques, which leads to post-operative complications and eventually hepatic failure\[[@B19]\]. During liver surgery, it is vital to minimize bleeding, especially from small blood vessels of liver parenchyma, in order to prevent intraoperative blood loss and to better visualize the surgical field\[[@B19]\].

In this study, we compared the efficacy, haemostatic properties, and biocompatibility of a novel, polyurethane based synthetic adhesive, MAR-1, with that of Fibrin, which is a clinically used medical adhesive.

Fibrin sealants mimic the coagulation cascade, which depends on various factors such as enzymes, proteins, and co-factors\[[@B20]\]. Polyurethane-based adhesives mainly react with the amino groups of proteins in the tissue, which enables the formation of urea linkages and eventually adhesion\[[@B12]\]. Polyurethanes are known to activate platelets, which enhances the blood clotting process\[[@B21]\]. Moreover, polyurethanes have demonstrated strong thrombogenic properties due to their hydrophobic nature, this promotes the proteins to adhere and initiate the coagulation cascade\[[@B12]\]. We measured the bleeding mass and time to assess the capacity of these sealants to stop bleeding after liver resection. The results showed no significant differences between the two sealants and the results were comparable. However, we noticed a significant difference between MAR-1, Fibrin and NaCl groups, this clearly showed the effectiveness of a sealant in minimizing blood loss, thereby reducing the bleeding time. On the other hand, liver parenchymal enzymes, AST and ALT, were measured and we noticed no significant changes in AST levels throughout the time course; whereas, a significant increase in ALT levels were seen in MAR-1 group after 21 d, in comparison to Fibrin and NaCl groups. AST and ALT levels are routinely measured to assess the functionality of liver and their ratio between the concentrations is of clinical relevance. AST/ALT ratio of 2:1 or more is considered as a sign of liver damage. The elevated ALT levels in the MAR-1 group was probably due to repeated manipulation of the liver lobe during the surgical procedure. Nevertheless, the values were within the physiological range and did not increase at a later time point.

Depending on the origin of thrombin in the fibrin sealants, severe immune reactions have been observed, leading to anaphylactic shock in some cases\[[@B22]-[@B24]\]. When extracted from human pooled blood, it carries a high risk of viral contamination\[[@B25],[@B26]\]. Despite improved methods of viral inactivation\[[@B27]\], it still carries a risk of parvovirus infection\[[@B28]\]. Whereas, MAR-1, the polyurethane based adhesive, showed no adverse reaction in this study. Polyurethanes in general are considered biocompatible and biodegradable; they are polymers consisting of urethane links\[[@B13]\]. Research has shown that polyurethanes containing biodegradable diisocyanates degrade into non-cytotoxic decomposition products\[[@B13],[@B29],[@B30]\]. After 14 d, the quantity of MAR-1 was either negligible or absent in the abdominal cavity, suggesting the rapid and efficient degradation of the glue. These results were significant in comparison to Fibrin glue, which was present even after 21 d. Nevertheless, both the glues were efficiently degraded by the end of 90 d. Meanwhile, it was difficult to visualize MAR-1 with the help of μCT, which can be attributed to its hydrogel like properties causing low contrast to the adjacent liver tissue. Studies have suggested that degradation of polyurethanes was mainly dependent on the polyester polyol composition\[[@B13],[@B31],[@B32]\]. Polyurethanes exhibit great versatility in their polymeric properties. Rapid degradation of MAR-1 proves its biocompatibility without any adverse effects. This also supported the previously established properties of polyurethanes such as toughness, durability, elasticity, biocompatibility, which is not achieved by any other available material\[[@B33]\].

Intra-abdominal adhesions are commonly noticed after abdominal surgery. Their incidence is estimated at 67%-93%, which affects the final outcome of the surgery\[[@B34]\]. When a foreign body is introduced into the abdominal cavity it leads to fibrosis and adhesion formation\[[@B35]\]. Demirel et al\[[@B36]\] showed that fibrin sealant drastically reduced adhesions in comparison to primary suture. In general, polyurethanes have been known to exhibit strong adhesion to the tissue\[[@B37]\], as mentioned earlier, their interaction with the amino acids results in the adhesion of the glue to the tissue\[[@B12]\]. We noticed the formation of adhesions during the time course; however, there were no significant differences between MAR-1 and Fibrin treated animals. However, significantly more adhesions were noticed in NaCl group compared to MAR-1 group. These results supports our hypothesis, which is the biocompatibility and non-inferiority of MAR-1 compared to Fibrin glue, the clinical gold standard. Furthermore, the survival rate showed no significant differences between the groups. Meanwhile, the histopathological examination revealed a few structural changes, however, the tissue sections failed to show any significant differences between the groups.

In summary, MAR-1 has been shown to be non-inferior to Fibrin in terms of effective and safe sealing of a liver in a resection model. Based on the obtained results, MAR-1 is biocompatible and showed no adverse effects. We agree that further research is needed to study the chemistry and biodegradability. Nevertheless, MAR-1 is ready to be used in its current form as a topical wound sealant. Moreover, due to the fully synthetic nature, there is no risk of increased immune reactions or viral transmission like with Fibrin.
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